These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 3906360)

  • 1. Diabetes, lipoproteins, and atherosclerosis.
    Schonfeld G
    Metabolism; 1985 Dec; 34(12 Suppl 1):45-50. PubMed ID: 3906360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The dyslipoproteinemias of diabetes.
    Steiner G
    Atherosclerosis; 1994 Oct; 110 Suppl():S27-33. PubMed ID: 7857380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New concepts about the pathogenesis of atherosclerosis in diabetes mellitus.
    Colwell JA; Winocour PD; Lopes-Virella M; Halushka PV
    Am J Med; 1983 Nov; 75(5B):67-80. PubMed ID: 6424441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Insulin-dependent diabetes and lipoprotein metabolism].
    Berthezène F; Perrot L; Valentin C; Sautot G
    Journ Annu Diabetol Hotel Dieu; 1984; ():115-23. PubMed ID: 6399527
    [No Abstract]   [Full Text] [Related]  

  • 5. [Abnormalities of lipid metabolism in diabetes mellitus].
    Murase T
    Nihon Rinsho; 1990 Dec; 48 Suppl():652-8. PubMed ID: 2086946
    [No Abstract]   [Full Text] [Related]  

  • 6. [Abnormal lipoprotein composition in normolipidemic diabetic subjects].
    Yoshino G; Kazumi T; Baba S
    Nihon Rinsho; 1990 Dec; 48 Suppl():659-67. PubMed ID: 2086947
    [No Abstract]   [Full Text] [Related]  

  • 7. [Progress in the study of lipoprotein metabolism and atherosclerosis: glycosylated beta-lipoprotein and atherosclerosis complicated by diabetes].
    Hayakawa M; Ando F; Kuzuya F
    Nihon Rinsho; 1988 Mar; 46(3):665-70. PubMed ID: 3404693
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of oral contraceptives on lipid metabolism.
    Krauss RM
    J Reprod Med; 1986 Jun; 31(6 Suppl):549-50. PubMed ID: 3723487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma lipoproteins and atherosclerosis.
    Tikkanen MJ
    J Diabet Complications; 1990; 4(2):35-8. PubMed ID: 2145293
    [No Abstract]   [Full Text] [Related]  

  • 10. Atherosclerosis and lipoprotein metabolism: role of reverse cholesterol transport.
    Roheim PS
    Am J Cardiol; 1986 Feb; 57(5):3C-10C. PubMed ID: 3511664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atherogenic, dense low-density lipoproteins. Pathophysiology and new therapeutic approaches.
    Chapman MJ; Guérin M; Bruckert E
    Eur Heart J; 1998 Feb; 19 Suppl A():A24-30. PubMed ID: 9519339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypertriglyceridemia and atherosclerosis analysis of an abnormal lipoprotein system and potential beneficial effects of triglyceride lowering therapy.
    Eisenberg S
    Adv Exp Med Biol; 1985; 183():73-84. PubMed ID: 4036705
    [No Abstract]   [Full Text] [Related]  

  • 13. [Lipoprotein glycation and glycoxidation: their importance in diabetes mellitus].
    Actis Dato SM; Rebolledo OR
    Medicina (B Aires); 2000; 60(5 Pt 1):645-56. PubMed ID: 11188909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin and lipoprotein metabolism with special reference to the diabetic state.
    Tomkin GH; Owens D
    Diabetes Metab Rev; 1994 Oct; 10(3):225-52. PubMed ID: 7835171
    [No Abstract]   [Full Text] [Related]  

  • 15. [Glycosylated lipoproteins as atherogenic factor in diabetes (review of the literature)].
    Denisenko TV
    Vopr Med Khim; 1990; 36(2):5-10. PubMed ID: 2194367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atherogenic lipoproteins resulting from genetic defects of apolipoproteins B and E.
    Weisgraber KH; Innerarity TL; Rall SC; Mahley RW
    Ann N Y Acad Sci; 1990; 598():37-48. PubMed ID: 2248450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acetoacetylated lipoproteins used to distinguish fibroblasts from macrophages in vitro by fluorescence microscopy.
    Pitas RE; Innerarity TL; Weinstein JN; Mahley RW
    Arteriosclerosis; 1981; 1(3):177-85. PubMed ID: 6895305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Metabolism of atherogenic lipoproteins].
    Beucler I; Turpin G
    Ann Med Interne (Paris); 2001 Apr; 152(3):158-61. PubMed ID: 11431574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-dependent action of atorvastatin in type IIB hyperlipidemia: preferential and progressive reduction of atherogenic apoB-containing lipoprotein subclasses (VLDL-2, IDL, small dense LDL) and stimulation of cellular cholesterol efflux.
    Guerin M; Egger P; Soudant C; Le Goff W; van Tol A; Dupuis R; Chapman MJ
    Atherosclerosis; 2002 Aug; 163(2):287-96. PubMed ID: 12052475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural peculiarities of the binding of very low density lipoproteins and low density lipoproteins to the LDL receptor in hypertriglyceridemia: role of apolipoprotein E.
    Dergunov AD; Smirnova EA; Merched A; Visvikis S; Siest G; Yakushkin VV; Tsibulsky V
    Biochim Biophys Acta; 2000 Feb; 1484(1):29-40. PubMed ID: 10685028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.